David Dobrodt

In her weekly dialogue, Schiller Institute Founder Helga Zepp-LaRouche evoked the principle of statecraft as developed by Friedrich Schiller as the means by which the present dominant global paradigm can be swept away. She reviewed how that paradigm is threatened by a systemic collapse, but as long as the method of the thinking imposed by the oligarchy remains hegemonic, we face a worsening world situation of pandemics, famine and war.

The alternative requires a new idea of politics, in which citizens elevate the quality of thinking to a new level. Zepp-LaRouche said that Schiller provided the means to achieve this, in his Aesthetical Letters, in which he argues that “true political freedom is the highest form of art.” In the battles ahead, including that of reversing the election theft of the 2020 election, the defense of the ideals of a constitutional republic requires that citizens come to distinguish between the real enemies of the U.S., centered in the City of London, and potential allies, such as Russia and China.

She concluded by urging that to accomplish this essential goal of elevating the level of thinking of the citizenry, the “Beethoven Year” should be extended, until a majority of people are able to “Think like Beethoven.”

Join us LIVE at 2pm EST. Today’s meeting will feature Dennis Speed, Diane Sare and Matthew Ogden.

As the drumbeat for war grows louder, and the near-misses in the air and near-collisions at sea more numerous, it is more urgent than ever that a summit of major powers happen, as soon as possible. The escalation in rhetoric against Russia and Putin over the narrative being spread about the Navalny “poisoning” — being spread with the usual help of Britain’s Porton Down chemical warfare center and the British-directed media — may have been the deciding factor in Putin’s decision to not attend the UNGA in New York this month.

The exposure of a coup faction among retired military, by former JAG officer Col. Richard Black at last weekend’s Schiller Institute (SI) conference, is reverberating widely, as it reflects the view of patriotic military officials who reject the idea of a coup against Trump. The President himself, in his Labor Day press conference, drew attention to the role of the war party, referring to Eisenhower’s warning about the Military Industrial Complex, and the decision announced on Wednesday to withdraw U.S. troops from Iraq demonstrates his intent to move on his pledge to end the “endless wars.”

In discussing this dangerous strategic situation, Helga Zepp-LaRouche urged viewers to use the video proceedings of the SI conference to elevate the level of dialogue in the population. The question that must be posed is, “Do you want war or peace?” If you want peace, join our mobilization to ensure a summit takes place BEFORE the election, as it will become more difficult as time passes, especially as the war party is building for a full-fledged constitutional crisis around the election.

An article in the Dec. 3 China Briefing, titled “China’s COVID-19 Vaccine Development and Availability,” names four of China’s vaccine-producers: the Tianjin-based CanSino; the Wuhan-based China National Biotech Group (CNBG), the Beijing-based Sinovac, and ZLongkema, based in Anhui province. These pharma companies have arrangements to carry out testing and distribution of vaccines in 14 developing sector countries, primarily in Ibero-America and Southwest Asia. Recently, China’s Sinovac licensed Brazil’s respected Butantan Institute to get raw materials to manufacture millions of doses of its COVID vaccine inside Brazil. China has the scientific knowledge, manpower, strong Hamiltonian finances, and production engineering skills capabilities to teach other countries to set up vaccine production factories within their borders, to the effect, perhaps, of expanding vaccine production by 1 to 2 billion doses.

The United States has strong capabilities. Were the U.S. to apply the Defense Production Act of 1950 to expand vaccine-manufacturing facilities, it could greatly add to this process, under HHS’s Operation Warp Speed.

The international organization COVAX was formed decades ago, as a joint fund for equitable distribution of vaccines, joining with an organization named Gavi, a funder of vaccines for low-income countries based in Geneva, Switzerland. On Dec. 18, COVAX announced that through contributions, it has pledged that at least 1.3 billion donor-funded vaccine doses will be made available to 92 low- and middle-income economies that are eligible. This valuable immunization initiative would fund only approximately enough vaccine to vaccinate a targeted 20% of the population.

These nations cannot wait until 2023-24 to get sufficient COVID-19 vaccine. The production facilities must be constructed so that the vaccine is available to a considerable share of those nations’ population by the first quarter of 2021. This will require not only vaccines per se, but also the refrigeration chains and other basic infrastructure required to deliver the doses to the targeted population. The method to address this was outlined in the LaRouche plan “Reopen the U.S. Economy: The World Needs 1.5 Billion New, Productive Jobs.”

Excerpts from Panel 1 of the September 5-6 Schiller Institute conference.

Watch the whole panel here: https://youtu.be/np673ypliKM

Speakers include:

Helga Zepp-LaRouche
Founder and chairwoman of the Schiller Institute
Greetings and Opening Remarks

Lyndon H. LaRouche Jr. (1922-2019)
Speech delivered to the 2000 Labor Day Schiller Institute conference

Andrey Kortunov
Director General of the Russian International Affairs Council
The Strategic Implications of the Russia-United States Bilateral Relationship

Dr. Natalia Vitrenko
Doctor of Economics, Chairwoman of the Progressive Socialist Party of Ukraine
Irreconcilable Problems Are Pushing the World Towards Catastrophe

Colonel Richard H. Black (USA, Ret.)
Former head of the Army’s Criminal Law Division at the Pentagon; former State Senator, Virginia
Do We Risk a Military Coup?

J. Kirk Wiebe
Former Senior National Security Agency (NSA) analyst
The Unnecessary Tragedy of 9/11

William Binney
Former technical director of the World Geopolitical and Military Analysis and Reporting section of the National Security Agency (NSA)
Defend the Constitution from the Surveillance State

A great increase in vaccine-making production capacity is needed globally, if billions of people in Ibero-America, Africa, and Asia are to have access to COVID-19 vaccines in a timely fashion to save tens of millions of lives—and if those populations are not to be made into a petri dish for breeding new mutations and new viruses to reinfect nations who survived the first round.

The following is a preliminary look at existing production capacity for COVID-19 vaccines, and what emergency measures and new construction would be needed to ensure success.

In a Dec. 8 interview with Bloomberg television, Rasmus Bech Hansen, founder and CEO of Airfinity, a life-sciences analytics firm that is currently focusing on SAR-CoV-2 virus, said that 6 billion of the world’s present 7.8 billion people would need to be vaccinated in order for COVID-19 to be defeated. This involves mass vaccination for about 75% of the world’s population.

But that is not occurring; the developing sector is, for the most part, being left out of plans for immediate or near-term vaccination. This means death for them, and continuing danger of contagion for the entire human race. A Nov. 30 article in Nature magazine, entitled, “How COVID Vaccines Are Being Divvied Up Around the World,” reports that vaccine-makers specializing in COVID vaccines, “can make sufficient doses for more than one-third of the world’s population by the end of 2021. But many people in low-income countries might have to wait until 2023 or 2024 for vaccination, according to estimates from the Duke Global Health Innovation Center in Durham, North Carolina.”

Nature further reports that “27 members of the European Union, together with five rich countries, have pre-ordered about half [of vaccine doses]. The countries account for only around 13% of the global population.”

To gain a sense of overall production capacity, the estimated capacity for 2021 for the major vaccine-makers, in billions of doses, is: AstraZeneca, 3 billion; Pfizer/BioNTech, 1.3 billion; Moderna, 1 billion; Russia’s Gamaleya National Center of Epidemiology (which makes Russia’s Sputnik V), 800 million.

Other vaccine-makers, including Johnson & Johnson/Janssen, Novanax, and others, may have the combined capacity to produce another 1.5 billion doses, bringing the total doses to 7.6 billion. But these figures may be overstated. For example, Russia does not have sufficient vaccine-making capacity inside Russia to make the vaccines it has committed to for foreign countries. Many pharma companies make projections of what they would like to produce, but do not reach them, and so forth.